Barrington Lifts PT on Haemonetics (HAE) to $50; Sees as Best Option for ARC Contract
Tweet Send to a Friend
Barrington reiterates its Outperform rating and raises its price target on Haemonetics Corp. (NYSE: HAE) from $45 to $50 following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
